Grants are sums of money given to help further the goals of small businesses or individuals. They can be awarded by government entities or private businesses. Unlike a loan, grants do not need to be repaid.
565 grants found
The purpose of this Funding Opportunity Announcement (FOA) is to support enhanced human and animal food safety by strengthening the capacity, collaboration, and integration of food-safety laboratories and networks, thereby facilitating an effective and coordinated response to future human and animal food safety issues.
This announcement represents the continuation of an AHRQ program that provides support to individuals who are conducting research undertaken as part of an accredited academic program to qualify for a research doctorate degree.
The goals of this initiative are to discover allelic variants, genomic alterations, and functional changes associated with addictive behaviors in non-human animals through systems studies that employ genetic and genomics strategies.
The purpose of the R03 grant program is (1) to develop an understanding of the risks and conditions associated with occupational diseases and injuries, (2) to explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and (3) to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.
The purpose of the NIOSH Mentored Research Scientist Development Award (K01) is to provide support and 75% “protected time” for an intensive, supervised (mentored) career development experience in occupational health and safety research leading to research independence.
The purpose of the R21 grant program is (1) to develop an understanding of the risks and conditions associated with occupational diseases and injuries, (2) to explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and (3) to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.
The purpose of the R01 grant program is (1) to develop an understanding of the risks and conditions associated with occupational diseases and injuries, (2) to explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and (3) to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.
This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying Substance Use Disorders (SUD), including fundamental brain function relevant to substance use.
The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.
The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.
The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program.
The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program.
The National Institute on Drug Abuse is issuing this Notice to highlight its interest in preclinical and clinical research to advance the understanding of the effects of concomitant use of opioids and stimulants.
The purpose of this Notice is to inform potential applicants to the National Institute on Drug Abuse (NIDA) about a special interest in research project applications focusing on discovery, development and validation of drug addiction biomarkers, biosignatures and elucidation of substance use disorder biotypes, with an emphasis on machine learning and artificial intelligence ( AI) based analytical approaches.
The purpose of this Notice of Special Interest (NOSI) is to solicit investigator-initiated applications to develop statistical, computational, and population genetics approaches to modeling polygenic risk in human populations, especially in genetically diverse populations.
To facilitate genomic research and the dissemination of its products, NHGRI supports genomic resources that are crucial for basic research, disease studies, model organism studies, and other biomedical research.
With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications.
The purpose of this NOSI is to communicate NHGRI’s special interest in potential applications under the Biomedical Data Repository (PAR-20-089) and Knowledgebase (PAR-20-097) FOAs, focused on the establishment of new, or continued development of established genomic data resources that use state-of-the-art and cost-effective technologies and approaches, and that are of high value to the broad genomic research community.
The purpose of this Notice is to inform potential applicants of the special interest of the National Cancer Institute (NCI) in promoting research on understanding and enhancing oral anticancer medication utilization, adherence, and health care delivery.
The purpose of this Notice is to communicate the National Institute on Drug Abuse's (NIDA) interest in advancing the development of pharmacological and non-pharmacological interventions for the HIV /HCV/ Substance Use Disorders (SUD) syndemic. The ultimate goal of this endeavor is to reduce the burden of HIV/HCV/SUD by discovering safe and effective therapeutic approaches for these health conditions.